340 B Drug Pricing

The National Law Review selected Bryan P. Murray of Dinsmore & Shohl as a Go To Thought Leader for his coverage of 340B Drug Pricing. Mr. Murray’s extensive analysis included U.S. HRS 340B COVID-19 resources and regulations, 340B civil penalties, Health and Human Services (HHS) regulatory rules, and more. NLR readers appreciate Mr. Murray’s comprehensive coverage of the topic, making him a go-to source for the latest news on 340B drug pricing.